BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Mello RA, Marques AM, Araújo A. Epidermal growth factor receptor and metastatic colorectal cancer: Insights into target therapies. World J Gastroenterol 2013; 19(38): 6315-6318 [PMID: 24151349 DOI: 10.3748/wjg.v19.i38.6315]
URL: https://www.wjgnet.com/1007-9327/full/v19/i38/6315.htm
Number Citing Articles
1
N.P. Malek, M. Bitzer. Neue Medikamente in der OnkologieDer Internist 2014; 55(4): 359 doi: 10.1007/s00108-013-3414-5
2
Zhanlong Shen, Bo Wang, Jianyuan Luo, Kewei Jiang, Hui Zhang, Harri Mustonen, Pauli Puolakkainen, Jun Zhu, Yingjiang Ye, Shan Wang. Global-scale profiling of differential expressed lysine acetylated proteins in colorectal cancer tumors and paired liver metastasesJournal of Proteomics 2016; 142: 24 doi: 10.1016/j.jprot.2016.05.002
3
Derya Okuyan. Epidermal Growth Factor Downregulates Carbon Anhydrase III (CAIII) in Colon CancerCurrent Issues in Molecular Biology 2024; 46(11): 12994 doi: 10.3390/cimb46110774
4
Hyun Min Ko, Wona Jee, Do-il Park, Kwan-Il Kim, Ji Hoon Jung, Hyeung-Jin Jang. The Antitumor Effect of Timosaponin A3 through c-Myc Inhibition in Colorectal Cancer Cells and Combined Treatment Effect with 5-FU or DoxorubicinInternational Journal of Molecular Sciences 2022; 23(19): 11900 doi: 10.3390/ijms231911900
5
Ji Hoon Jung, Deok-Beom Jung, Hyunseok Kim, Hyemin Lee, Shi-Eun Kang, Sanjay K. Srivastava, Miyong Yun, Sung-Hoon Kim. Zinc finger protein 746 promotes colorectal cancer progression via c-Myc stability mediated by glycogen synthase kinase 3β and F-box and WD repeat domain-containing 7Oncogene 2018; 37(27): 3715 doi: 10.1038/s41388-018-0225-0